PortfoliosLab logoPortfoliosLab logo
Prestige Consumer Healthcare Inc. (PBH)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US74112D1019
CUSIP
74112D101
IPO Date
Feb 10, 2005

Highlights

Market Cap
$2.85B
Enterprise Value
$2.84B
EPS (TTM)
$3.80
PE Ratio
15.59
PEG Ratio
1.33
Total Revenue (TTM)
$1.10B
Gross Profit (TTM)
$622.30M
EBITDA (TTM)
$336.08M
Year Range
$57.25 - $89.37
Target Price
$66.00
ROA (TTM)
5.34%
ROE (TTM)
10.19%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Prestige Consumer Healthcare Inc.

Often compared with PBH:
PBH vs. HYGPBH vs. MWA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Prestige Consumer Healthcare Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Prestige Consumer Healthcare Inc. (PBH) has returned -3.92% so far this year and -31.06% over the past 12 months. Over the last ten years, PBH has returned 0.91% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Prestige Consumer Healthcare Inc.

1D
1.30%
1M
-14.47%
YTD
-3.92%
6M
-5.02%
1Y
-31.06%
3Y*
-1.82%
5Y*
6.59%
10Y*
0.91%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 10, 2005, PBH's average daily return is +0.05%, while the average monthly return is +0.98%. At this rate, your investment would double in approximately 5.9 years.

Historically, 53% of months were positive and 47% were negative. The best month was Dec 2008 with a return of +34.9%, while the worst month was Jul 2005 at -42.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.

On a daily basis, PBH closed higher 51% of trading days. The best single day was May 10, 2018 with a return of +23.7%, while the worst single day was Jul 28, 2005 at -40.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20264.51%7.49%-14.47%-3.92%
2025-1.69%10.39%1.44%-5.51%5.47%-6.79%-7.39%-7.99%-8.29%-2.88%-1.73%3.59%-21.00%
20240.52%13.06%4.28%-1.10%-10.38%7.06%2.85%5.41%-3.40%2.29%14.94%-7.88%27.56%
20235.05%-8.38%3.95%-1.76%-6.99%3.84%9.73%-10.55%-1.95%3.79%-3.39%6.75%-2.20%
2022-6.92%5.46%-11.07%3.25%2.12%5.34%2.57%-16.13%-1.48%9.33%12.81%1.85%3.22%
202114.71%4.28%5.68%-1.18%14.49%4.47%0.86%9.21%-2.23%6.91%-6.73%8.40%73.93%

Benchmark Metrics

Prestige Consumer Healthcare Inc. has an annualized alpha of 4.50%, beta of 0.87, and R² of 0.19 versus S&P 500 Index. Calculated based on daily prices since February 11, 2005.

  • This stock participated in 105.21% of S&P 500 Index downside but only 93.85% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.19 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
4.50%
Beta
0.87
0.19
Upside Capture
93.85%
Downside Capture
105.21%

Return for Risk

Risk / Return Rank

PBH ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


PBH Risk / Return Rank: 77
Overall Rank
PBH Sharpe Ratio Rank: 11
Sharpe Ratio Rank
PBH Sortino Ratio Rank: 33
Sortino Ratio Rank
PBH Omega Ratio Rank: 55
Omega Ratio Rank
PBH Calmar Ratio Rank: 99
Calmar Ratio Rank
PBH Martin Ratio Rank: 1515
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Prestige Consumer Healthcare Inc. (PBH) and compare them to a chosen benchmark (S&P 500 Index).


PBHBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-1.22

0.90

-2.12

Sortino ratio

Return per unit of downside risk

-1.72

1.39

-3.11

Omega ratio

Gain probability vs. loss probability

0.79

1.21

-0.42

Calmar ratio

Return relative to maximum drawdown

-0.86

1.40

-2.25

Martin ratio

Return relative to average drawdown

-1.27

6.61

-7.88

Explore PBH risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Prestige Consumer Healthcare Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Prestige Consumer Healthcare Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Prestige Consumer Healthcare Inc. was 80.60%, occurring on Mar 11, 2009. Recovery took 935 trading sessions.

The current Prestige Consumer Healthcare Inc. drawdown is 33.47%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-80.6%Jul 11, 2005924Mar 11, 2009935Nov 26, 20121859
-53.75%Mar 2, 2017509Mar 11, 2019608Aug 6, 20211117
-35.49%May 19, 2025132Nov 24, 2025
-27.12%Dec 27, 201328Feb 6, 2014190Nov 6, 2014218
-23.03%Nov 12, 2021219Sep 27, 202247Dec 2, 2022266

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Prestige Consumer Healthcare Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Prestige Consumer Healthcare Inc. is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for PBH, comparing it with other companies in the Medical Distribution industry. Currently, PBH has a P/E ratio of 15.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for PBH compared to other companies in the Medical Distribution industry. PBH currently has a PEG ratio of 1.3. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for PBH relative to other companies in the Medical Distribution industry. Currently, PBH has a P/S ratio of 2.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for PBH in comparison with other companies in the Medical Distribution industry. Currently, PBH has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items